Uridine's Role in Reducing 5-Fluorouracil Toxicity
Author Information
Author(s): G.J. Peters, J. van Dijk, E. Laurensse, C.J. van Groeningen, J. Lankelma, A. Leyva, J.C. Nadal, H.M. Pinedo
Primary Institution: Free University Hospital
Hypothesis
Can delayed administration of uridine reduce the toxicity of 5-fluorouracil while maintaining its antitumor efficacy?
Conclusion
Delayed administration of uridine after 5-fluorouracil treatment improved therapeutic effects and reduced toxicity in both resistant and sensitive tumors.
Supporting Evidence
- Uridine at 0.1 mM could reverse the cytotoxic effects of 5-fluorouracil in cell culture.
- Delayed uridine administration allowed for higher doses of 5-fluorouracil to be used without increasing toxicity.
- Leukopenia caused by 5-fluorouracil was less severe with uridine treatment.
Takeaway
This study shows that giving uridine after a cancer drug called 5-fluorouracil can help make the drug work better and hurt the body less.
Methodology
The study involved in vitro growth inhibition assays on human intestinal cell lines and in vivo experiments on mice with colon carcinoma tumors.
Limitations
The study primarily used murine models, which may not fully represent human responses.
Participant Demographics
Mice used included BALB/c and C57B1/6 strains.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website